Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Medlab Asia and Asia Health to Host First-Ever Live, In-Person Event in Thailand

By LabMedica International staff writers
Posted on 27 Jul 2022

Informa Markets (London, UK), in partnership with Impact Muang Thong Thani (Nonthaburi, Thailand), have confirmed that Medlab Asia and Asia Health will take place in Thailand for the first time when the co-located events return live and in-person at the Impact Exhibition Center, Bangkok, from 19-21 October 2022. More...

The exhibitions, the leading events in the ASEAN region for the healthcare and laboratory industry, will showcase the latest techniques and innovations while also welcoming visitors and suppliers from around the world to meet, discuss and do business in the burgeoning healthcare hub of Thailand.

According to government data, sales of clinical laboratory services in Thailand are expected to increase to USD 8.3 billion in 2026, from USD 4.5 billion in 2016. The healthcare sector in the country has also seen a surge in the number of international patients it welcomes, with current figures standing at two million. However, this figure is expected to increase. The co-located events are expected to welcome more than 4,200 attendees during the 10th edition of both events, with more than 300 exhibitors from over 20 countries showcasing the latest innovation in product development and new technologies and insights supporting the healthcare and laboratory industries. Both events are once again expected to be supported by a host of government entities, industry leaders and influencers in their respective sectors.

Forming a vital attribute of both events are the CME, CMTE, CNEU & CPD accredited conferences, each designed to provide peer-to-peer networking while fostering knowledge through insights and expert analysis. Medlab Asia will host six conference tracks, including Laboratory Management, Clinical Chemistry, Clinical Microbiology, Molecular Diagnostics & Therapeutics, Hematology and COVID-19 Updates. The congress focus for Asia Health will look, in detail, at Hospital Procurement, Sterilization, Decontamination & Patient Safety, Doing Healthcare Business in Thailand and Total Radiology. This will be supported by workshops featuring latest technologies in the ASEAN healthcare sector.

A host of exhibitors have already committed to attending the three-day showcase. They include, amongst others, Randox laboratories Ltd, Singapore-based GenScript Biotech, College of American Pathologists, Trivitron Healthcare, Sysmex Asia Pacific, BGI Genomics Co, and Sansure Biotech. As part of Informa's commitment to providing the highest hygiene and safety levels, the event will again take place under the protocols introduced via the company’s Informa AllSecure health and safety mandate. The enhanced measures include 35 guidelines covering all aspects of cleaning and hygiene, social distancing measures, screening, and a track and trace in conjunction with local authorities.

“We are delighted to be relaunching Medlab Asia and Asia Health as a co-located event in Thailand. Both events have been integral to developing the healthcare and laboratory sectors in the ASEAN region over the last decade,” said Tom Coleman, Exhibition Director for Informa Markets. “This is something we are committed to continuing, to ensure the latest technology and insights are given a platform in the region and that both events continue to play a pivotal role in connecting those within the healthcare and laboratory industries.”

“The healthcare industry has faced unprecedented challenges in recent years; however, the industry should be applauded for its efforts in supporting the recovery of businesses globally while also ensuring economic recovery,” added Loy Joon How, General Manager, Impact Muang Thong Thani.

Related Links:
Informa Markets 
Impact Muang Thong Thani
Medlab Asia 
Asia Health 


New
Gold Member
Collection and Transport System
PurSafe Plus®
Collection and Transport System
PurSafe Plus®
Automated Biochemical Analyzer
iBC 900
New
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: AiPlex VAS for the MosaiQ platform is designed to help reduce time-to-diagnosis for patients with autoimmune vasculitis (Photo courtesy of AliveDx)

Novel Multiplex Assay Supports Diagnosis of Autoimmune Vasculitis

Autoimmune vasculitis and related conditions are difficult to diagnose quickly and accurately, often requiring multiple tests to confirm the presence of specific autoantibodies. Traditional methods can... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.